- Open Access
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
Arthritis Research & Therapyvolume 21, Article number: 69 (2019)
The original article was published in Arthritis Research & Therapy 2019 21:54
Correction to: Arthritis Res Ther
Following publication of the original article , the authors reported an error in the spelling of Lorenzo Dagna’s name. The authors apologise for the error.
The original article  has been updated.
Cavalli, et al. Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease. Arthritis Res Ther. 2019;21:54 https://doi.org/10.1186/s13075-019-1843-9.